133 Molesworth Street
PO Box 5013
Wellington 6140
New Zealand
T+64 4 496 2000
4 November 2022
Chris McCashin
By email: [FYI request #20204 email]
Ref:
H2022014805
Tēnā koe Chris
Transfer and response to your request for official information
Thank you for your request under the Official Information Act 1982 (the Act) to Manatū Hauora
(the Ministry of Health) on 14 October 2022. Please find a response to each part of your request
below:
1. You state there were no Covid memorandums prior to 7 May 2021. So please provide
me the scope of works with the CV-ISMB, how much they were paid by that date,
deliverables associated with CV-ISMB - what did they do if they didn't produce one memo
in the first five months of them being paid?
2. Medsafes own data confirms that TTS has occurred from the Pfizer vaccine - how can
you say this isn't a side effect from the Pfizer vaccine when there are over 60 side effects
registered on your own data that this is a side effect?
5. Please provide data as requested on the anaphalaxis - how many cases of anaphalaxis
were not recorded when measuring against the Brighton Collaboration
6. Were people prior to vaccination warned of all the safety signals?
7. A safety communication was issued - are these safety communications relayed to
people prior to vaccination? If not, why not?
10. I have read the minutes you don't need to link me through to stuff you have sent - what
is the average "under reporting" rate of vaccine injuries for this medication and previous
medications
11. This means nothing - you are studying people after you have injured them - a 400%
increase in Myocarditis and likely numerous delayed deaths through cardiac arythmia in
children is going to occur going forward in New Zealand and is already happening
overseas
12. Whilst the information is publically available are vaccinators warning of Myocarditis so
that New Zealanders get informed consent?
13. Please provide appendix one
14. I have read the safety signals - however are people warned of the safety signals per
informed consent process
These parts of your request ask for information which is more closely connected with the
functions of Te Whatu Ora (Health New Zealand). For this reason, the Manatū Hauora has
decided to transfer these parts of your request to Te Whatu Ora under section 14(b)(i ) of the
Act. You can expect a response from Te Whatu Ora in due course.
3. Thousands of dollars in compensation and treatment has been paid out by ACC for
vaccine side effects. Please provide all of the side effects that ACC has paid out on - are
there more side effects that ACC have been paid out on listed as possible side effects
4. The statement was issued yet since that date TTS has been registered with CARM - if
our own data registers TTS as a side effect why won't you acknowledge this - has ACC
paid out any compensation for TTS?
These parts of your request ask for information which is more closely connected with the
functions of the Accident Compensation Corporation (ACC). For this reason, the Manatū Hauora
has decided to transfer these parts of your request to ACC under section 14(b)(i ) of the Act.
You can expect a response from ACC in due course.
Turning now to the remaining parts of your request, please find a response from Manatū Hauora
below.
8. This memo mentions the benefits clearly outweigh the risks - what documents,
evidence were relied on that the benefits of a vaccine that does not stop you getting or
transmitting a virus with a 99% recovery rate outweigh the risks for a heart condition that
can ruin ones life (and has done including death in NZ)
We do not accept the premise of this part of your request. The Pfizer vaccine is an effective
means of reducing the transmission of COVID-19. You can find more information about the
efficacy of the vaccine here, on page 9:
www.medsafe.govt.nz/profs/Datasheet/c/comirnatyinj.pdf
Further information about transmission can be found here:
www.health.govt.nz/system/files/documents/pages/sars-cov-2-variant-of-concern-update-
27sep22.pdf
9. Please provide all the benefit / risk assessments based on the ever evolving
data. Please provide all of the documents used to assess efficacy, if it is better than a
placebo (comparison against placebo groups), alternative treatments considered, number
of people with condition, history of disease
The link you sent me through outlines the criteria when considering the benefits risks -
please provide all of the reports purporting this information and provide to me
Medsafe frequently monitors the safety of COVID-19 vaccinations and Adverse Events
Following Immunisation (AEFIs). You can find these vaccine reports here:
www.medsafe.govt.nz/COVID-19/vaccine-report-overview.asp
Manatū Hauora also regularly updates the Sciences News page with up-to-date information
regarding COVID-19 and vaccines:
www.health.govt.nz/covid-19-novel-coronavirus/covid-19-resources-and-tools/covid-19-science-
news
As stated earlier in this response, you can find information about the efficacy of the vaccine
here:
•
www.medsafe.govt.nz/profs/PUArticles/June2021/Spotlight-on-Comirnaty-vaccine.html
•
www.medsafe.govt.nz/profs/Datasheet/c/comirnatyinj.pdf
Page 2 of 3
The datasheet is not available - please provide links that work
We are sorry to hear that the links we provided did not work. If this happens again in future,
removing the full stop at the end of the link can resolve this issue. Below is the link to the main
page for Medsafe datasheets:
www.medsafe.govt.nz/Medicines/infoSearch.asp
Please provide all of the information / studies that Ministry of Health relied on to say the
vaccine would stop transmission which was part of the original messaging
Information regarding the vaccine and transmission can be found here:
www.health.govt.nz/system/files/documents/pages/sars-cov-2-variant-of-concern-update-
27sep22.pdf
I trust this information fulfils your request. Under section 28(3) of the Act, you have the right to
ask the Ombudsman to review any decisions made under this request. The Ombudsman may
be contacted by email at:
[email address] or by calling 0800 802 602.
Nāku noa, nā
Jan Torres
Manager, OIA Services
Government and Executive Services | Te Pou Whakatere Kāwanatanga
Page 3 of 3
